Selective Anticancer Therapy Based on a HA-CD44 Interaction Inhibitor Loaded on Polymeric Nanoparticles. (2022)
Attributed to:
The UK High-End Computing Consortium for Biomolecular Simulation
funded by
EPSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.3390/pharmaceutics14040788
PubMed Identifier: 35456622
Publication URI: http://europepmc.org/abstract/MED/35456622
Type: Journal Article/Review
Volume: 14
Parent Publication: Pharmaceutics
Issue: 4
ISSN: 1999-4923